FORT MILL, S.C., March 6, 2026
Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations, has announced that its LockeT™ suture retention device will be featured in live procedural demonstrations at the International Symposium of Left Atrial Appendage (ISLAA) 2026 conference. The event, held March 5–6, 2026, at the Biltmore Hotel in Los Angeles, California, brings together leading physicians, researchers, and electrophysiology specialists to discuss cutting-edge cardiovascular science and interventional techniques. The inclusion of LockeT in live clinical cases highlights growing interest in advanced wound closure technologies designed to improve procedural efficiency, reduce hospital costs, and support faster patient recovery.
Live Clinical Demonstrations Highlight Innovative Device
At ISLAA 2026, Catheter Precision’s LockeT device will be demonstrated during live cases involving left atrial appendage procedures, allowing clinicians to evaluate its performance in real-world clinical settings. The International Symposium of Left Atrial Appendage is recognized as a multidisciplinary cardiovascular education event, featuring program leadership from major medical institutions including The Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic, and Mount Sinai. The conference focuses on frontier science and evolving procedural strategies for managing left atrial appendage conditions, which are closely associated with atrial fibrillation and stroke risk.
By participating in live procedural sessions, Catheter Precision aims to provide physicians and electrophysiology fellows with hands-on exposure to the LockeT device, enabling them to explore its clinical advantages firsthand. The event also offers educational workshops and product demonstrations designed to help healthcare professionals understand innovative technologies that enhance interventional cardiology procedures. According to company leadership, live demonstrations represent one of the most effective ways for clinicians to validate the safety, efficiency, and economic value of new medical devices in real-world clinical workflows.
LockeT Device Designed to Improve Procedure Efficiency
Advertisement
The LockeT™ suture retention device is designed to assist physicians with wound closure following percutaneous venous punctures, a common step in many cardiac electrophysiology procedures. By securing sutures during closure, the device helps clinicians achieve more efficient and reliable wound management, potentially enabling same-day patient discharge and reducing hospital resource utilization. The device is classified as a Class I medical device registered with the U.S. Food and Drug Administration (FDA) and has also received CE Mark approval, allowing it to be used across multiple global healthcare markets.
Healthcare providers performing catheter-based cardiac procedures frequently require reliable closure techniques to ensure patient safety, minimize complications, and accelerate recovery times. Technologies such as LockeT aim to simplify this critical step by offering structured suture retention and stabilization, helping clinicians maintain control during post-procedure closure. As minimally invasive cardiovascular procedures continue to expand globally, innovations in supportive surgical tools and electrophysiology technologies are becoming increasingly important in improving both clinical outcomes and operational efficiency within healthcare systems.
Growing Focus on Innovation in Cardiac Electrophysiology
Catheter Precision continues to position itself as an innovator in the cardiac electrophysiology market, focusing on the development of technologies that improve treatment for cardiac arrhythmias and related cardiovascular conditions. The company collaborates closely with physicians to develop devices that address practical clinical challenges encountered during catheter-based interventions. By integrating physician feedback into product development, Catheter Precision aims to bring next-generation electrophysiology tools to hospitals and cardiovascular treatment centers worldwide.
Participation in major medical conferences such as ISLAA 2026 also allows the company to showcase its technology to a global audience of specialists while gathering valuable clinical insights that can guide future innovation. As cardiovascular disease continues to be a leading cause of morbidity and mortality worldwide, the demand for advanced interventional tools and procedural support technologies remains high. Devices like LockeT demonstrate how targeted innovations can help improve procedure workflow, patient safety, and healthcare cost efficiency in modern cardiovascular care.
With ongoing clinical engagement and product development initiatives, Catheter Precision aims to strengthen its role in the evolving field of electrophysiology and interventional cardiology, supporting clinicians with practical technologies designed to enhance procedural success and improve patient outcomes.
z
Source: Catheter Precision press release
